What is Abpro Holdings, Inc.?
, a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 1.42M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.